New Year brings new opportunities for people living with hepatitis C

More new medicines for hepatitis C will continue to become available in 2017 and they will be more effective across a range of hepatitis C genotypes.  From 1 January [grazoprevir + elbasvir], given as a once daily tablet, will be available on the PBS and presents a new option for people with genotype 4.

Read More

New insights into hepatitis B: Understanding the social and cultural experiences of people affected by hepatitis B

On 18 May 2016, the Australian Research Centre in Sex, Health and Society (ARCSHS) Blood Borne Virus Program and Cancer Council Victoria partnered with Hepatitis Australia to deliver the ‘New insights into hepatitis B: Understanding the social and cultural experiences of people affected by hepatitis B’

Read More